CNVI logo

Conavi Medical Corp. Stock Price

TSXV:CNVI Community·CA$41.4m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

CNVI Share Price Performance

CA$0.54
-0.03 (-5.26%)
CA$0.54
-0.03 (-5.26%)
Price CA$0.54

CNVI Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Low risk and slightly overvalued.

3 Risks
2 Rewards

Conavi Medical Corp. Key Details

CA$9.2m

Revenue

CA$1.9m

Cost of Revenue

CA$7.3m

Gross Profit

CA$37.1m

Other Expenses

-CA$29.8m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.39
79.35%
-322.74%
-155.0%
View Full Analysis

About CNVI

Founded
n/a
Employees
n/a
CEO
Thomas Looby
WebsiteView website
conavi.com

Conavi Medical Corp. focuses on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. It offers Novasight Hybrid System, a system that combines intravascular ultrasound and optical coherence tomography to enable simultaneous and co-registered imaging of coronary arteries. The company is based in Toronto, Canada.

Recent CNVI News & Updates

Recent updates

No updates